Join Our Community of Monthly Supporters to Fight Alzheimer’s Disease All Year Long
Join Our Community of Monthly Supporters to Fight Alzheimer’s Disease All Year Long
Help provide care and support for millions affected by Alzheimer’s and advance research to bring us closer to a cure all year long with a monthly gift.
Give MonthlyAlzheimer's Association Welcomes Revised Label for Aduhelm
The Alzheimer’s Association is pleased with the announcement today that the FDA has revised the prescribing label for Aduhelm™ (aducanumab).
“Today’s announcement is consistent with the Alzheimer’s Association position that Aduhelm should be made available specifically to the population represented in the clinical trials where there was evidence of clinical benefit,” said Maria C. Carrillo, Ph.D., Alzheimer’s Association chief science officer. “We appreciate the FDA’s thoughtful consideration and response to the Alzheimer’s Association and others in the community including physicians, researchers and patients to ensure this treatment is prescribed only to those who may see benefit.”
The Alzheimer’s Association is committed to working with the Centers for Medicare & Medicaid Services (CMS) — and the private payer community — to expedite access for the appropriate population, which has such significant need.
About the Alzheimer's Association
The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.